Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-004101
Filing Date
2024-02-16
Accepted
2024-02-16 16:10:25
Documents
1
Period of Report
2024-02-15

Document Format Files

Seq Description Document Type Size
1 form4-02162024_040218.html 4  
1 form4-02162024_040218.xml 4 5775
  Complete submission text file 0001415889-24-004101.txt   7315
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Issuer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O GRAPHITE BIO, INC. 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address
Young Alethia (Reporting) CIK: 0001918147 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35969 | Film No.: 24648427